TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer

Clinical trial NCT06251544 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06251544
Sponsor: Baylor College of Medicine
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Tumor, Breast Breast Tumor Malignant Neoplasm of Breast Mammary Cancer Mammary Neoplasm Mammary Neoplasms, Human Neoplasm, Breast

Start date: 2026-06-01
Primary completion: 2029-01-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.